 antihypertensive efficacy hydrochlorothiazide prostacyclin dependent hypothesis vascular prostacyclin synthesis hydrochlorothiazide drug antihypertensive effect patients mild essential hypertension randomized double-blind design effects indomethacin hydrochlorothiazide ability blood pressure alter body weight plasma renin activity vascular prostacyclin biosynthesis urinary excretion major metabolite prostacyclin alpha GC/MS Administration hydrochlorothiazide mg weeks significant decrease systolic diastolic blood pressure supine systolic mm Hg diastolic mm Hg upright systolic mm Hg diastolic mm Hg positions Hydrochlorothiazide administration kg weight loss stimulation plasma renin activity ng angiotensin I/ml/hr urinary excretion alpha unchanged administration hydrochlorothiazide creatinine placebo ng/gm week hydrochlorothiazide ng/gm week drug Administration indomethacin mg day inhibition alpha excretion antihypertensive response Indomethacin diuretic effect hydrochlorothiazide weight loss rise plasma renin activity data demonstrate blood pressure-lowering effect thiazide diuretic enhanced prostacyclin synthesis cyclooxygenase inhibitor indomethacin antihypertensive efficacy hydrochlorothiazide